VertigoDx Secures FDA 510(k) Clearance for SmartVertigo® Point-of-Care Vestibular Diagnostic System
Mobile platform combines smartphone technology, a proprietary light-occluding headset, and [...]
Professor Bill Sessa Appointed Chair of Isomab’s Scientific Advisory Board
Former Chief Scientific Officer of Internal Medicine at Pfizer: Leading [...]
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) [...]
Open-Source Model Accelerates Global Progress in Medical Video AI
Through an open-source model, a public dataset and benchmark, and [...]
Philanthropic Support from Dr. Marie and Mr. Vijay Goradia Enables Research Collaboration to Study 11h in Alzheimer’s Disease
Fannin-founded Goldenrod Therapeutics and UT Health San Antonio’s Glenn Biggs [...]
What Is Emotion Code Therapy? A Cautious Look at a Complementary Practice
The method attracts people seeking a non-clinical approach to emotional [...]
Direct Selective Laser Trabeculoplasty Shows Favorable Safety Profile
Preclinical study evaluates the safety of laser treatments used to [...]
Boston Scientific receives FDA clearance for SpaceOAR™ Flex Hydrogel
New addition to rectal spacing portfolio offers flexible hydrogel placement, [...]
Breast Cancer Continues to Impact Communities; Austin Rallies Together to Take Action at Susan G. Komen® Austin MORE THAN PINK Walk
Annual Event Unites Survivors, Those Living with Metastatic Breast Cancer, [...]
Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
Results presented at IMS 2026 show ZENBEXUS in combination with [...]